Atezolizumab is associated with enhanced response in triple-negative breast cancerMay 16, 2023Breast CancerOncology
Facial, hand, and foot dermatitis: Lebrikizumab and dupilumab show efficacy in new studiesMay 15, 2023Dermatology
BMI has greater impact on survival in younger breast cancer patientsMay 12, 2023Breast CancerWomen's HealthObesity
